Zurich Cantonal Bank’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$24.8M Buy
+74,920
New +$25.5M 0.05% 283
2025
Q4
Sell
-40,944
Closed -$18.1M 2580
2025
Q3
$18.7M Buy
40,944
+10,193
+33% +$4.15M 0.04% 337
2025
Q2
$10M Sell
30,751
-26,368
-46% -$7.3M 0.02% 469
2025
Q1
$15.4M Buy
57,119
+2,713
+5% +$697K 0.04% 358
2024
Q4
$12.8M Sell
54,406
-164
-0.3% -$43.1K 0.04% 384
2024
Q3
$15M Sell
54,570
-10,915
-17% -$2.84M 0.04% 346
2024
Q2
$15.9M Buy
65,485
+15,471
+31% +$2.44M 0.05% 311
2024
Q1
$7.47M Buy
50,014
+4,934
+11% +$823K 0.03% 459
2023
Q4
$8.63M Buy
45,080
+22,473
+99% +$3.83M 0.03% 420
2023
Q3
$4M Buy
22,607
+2,201
+11% +$420K 0.02% 563
2023
Q2
$3.88M Buy
20,406
+460
+2% +$91.2K 0.02% 572
2023
Q1
$4M Buy
19,946
+1,032
+5% +$217K 0.02% 548
2022
Q4
$4.49M Sell
18,914
-27,346
-59% -$5.83M 0.02% 498
2022
Q3
$9.26M Buy
46,260
+206
+0.4% +$39.3K 0.05% 321
2022
Q2
$6.72M Buy
46,054
+27,645
+150% +$3.92M 0.04% 398
2022
Q1
$3.01M Buy
18,409
+144
+0.8% +$21.9K 0.01% 627
2021
Q4
$3.1M Sell
18,265
-8,836
-33% -$1.64M 0.02% 640
2021
Q3
$5.12M Buy
27,101
+774
+3% +$145K 0.03% 508
2021
Q2
$4.46M Sell
26,327
-4
-0% -$586 0.02% 521
2021
Q1
$3.72M Buy
26,331
+351
+1% +$52.8K 0.02% 557
2020
Q4
$3.38M Buy
25,980
+102
+0.4% +$13.6K 0.02% 587
2020
Q3
$3.77M Buy
25,878
+2,417
+10% +$343K 0.03% 509
2020
Q2
$3.48M Sell
23,461
-1,040
-4% -$140K 0.03% 482
2020
Q1
$2.67M Buy
24,501
+1,043
+4% +$120K 0.03% 530
2019
Q4
$2.7M Buy
23,458
+5,047
+27% +$503K 0.02% 590
2019
Q3
$1.48M Buy
18,411
+998
+6% +$79K 0.01% 720
2019
Q2
$1.26M Sell
17,413
-585
-3% -$44.9K 0.01% 762
2019
Q1
$1.68M Sell
17,998
-200
-1% -$16.7K 0.02% 679
2018
Q4
$1.33M Sell
18,198
-416
-2% -$32K 0.01% 704
2018
Q3
$1.63M Buy
18,614
+300
+2% +$30.2K 0.01% 709
2018
Q2
$1.8M Sell
18,314
-1,721
-9% -$171K 0.02% 679
2018
Q1
$2.39M Buy
20,035
+361
+2% +$46.5K 0.02% 593
2017
Q4
$2.5M Buy
19,674
+14,462
+277% +$1.82M 0.02% 584
2017
Q3
$612K Buy
5,212
+1,700
+48% +$145K 0.01% 835
2017
Q2
$280K Buy
3,512
+618
+21% +$39.5K ﹤0.01% 904
2017
Q1
$148K Buy
+2,894
New +$134K ﹤0.01% 1116
2016
Q4
Sell
-14,648
Closed -$993K 2560
2016
Q3
$993K Buy
14,648
+5,400
+58% +$381K 0.01% 769
2016
Q2
$513K Buy
9,248
+940
+11% +$59.2K 0.01% 823
2016
Q1
$521K Hold
8,308
0.01% 828
2015
Q4
$782K Buy
8,308
+1,950
+31% +$181K 0.01% 752
2015
Q3
$511K Buy
6,358
+933
+17% +$104K 0.01% 828
2015
Q2
$650K Buy
5,425
+227
+4% +$27.1K 0.01% 792
2015
Q1
$543K Buy
+5,198
New +$527K 0.01% 820
2014
Q4
Sell
-10,000
Closed -$781K 973
2014
Q3
$781K Sell
10,000
-50,000
-83% -$3.23M 0.03% 582
2014
Q2
$3.79M Buy
60,000
+37,000
+161% +$2.2M 0.11% 225
2014
Q1
$1.54M Hold
23,000
0.05% 417
2013
Q4
$1.48M Buy
23,000
+2,000
+10% +$119K 0.05% 389
2013
Q3
$1.34M Buy
+21,000
New +$1.05M 0.05% 390

Other funds holding ALNY